Jafron Biomedical

🚀 "Exciting News" 🚀 We' re thrilled to share that Jafron products have been making a meaningful impact in patient care across five countries this November! Here' s a quick highlight of these remarkable results!   🌟 Philippines: Patient A, suffering from hepatic encephalopathy & needing a liver transplant, saw a significant reduction in bilirubin level and a steady recovery after just 7 times of DPMAS.   🌟 Colombia (Local First Case): Pediatric Patient B, suffering from congenital heart disease, had improved postoperative inflammatory control with HA60 during surgery.   🌟 Vietnam (First Case in this Hospital): Pesticide-poisoned Patient C became seizure-free after 5 days of HA230 & JF-800A treatment and transferred out of ICU.   🌟 Russia: Patient D, suffering from liver disease (severe mechanical jaundice), had no detectable Alb or PLT loss or new coagulation disorders and significant encephalopathy improvement with BS330 (PA).   🌟 Romania (First Case in this Hospital): After 20 sessions of HA130 treatments(once/w), the itching & neuropathy of Patient E disappeared, and she returned to normal life. #Jafron #HA60 #DPMAS #HA230 #HA130 

Jafron India Team in Action

Jafron India recently made a significant impact at the Delhi Critical Care Symposium (DCCS-2024) by showcasing our cutting-edge hemoadsorption therapy and transformative potential in critical care. The event was an excellent opportunity to engage with Indian healthcare professionals in academic dialogue, focusing on ways to improve toxicological treatment and reinforcing our commitment to advancing critical care. As key highlights, Jafron hosted an interactive workshop on hemoadsorption solutions for sepsis and multi-organ failure, featuring live product demonstrations. This hands-on experience attracted audiences to discuss the unique features and practical benefits of our products in clinical applications. We also engage in academic collaborations with KOLs in the industry to further explore the future of hemoadsorption technology, with our shared vision of enhancing patient outcomes. We are excited to continue this journey with the medical community and drive advancements that make a meaningful difference in critical care.

Congratulations to Mr. Dong Fan, Chairman of Jafron Biomedical, on being appointed Vice President of the All-China Federation of Industry and Commerce Medical and Pharmaceutical Commercial Association (CMP). The All-China Federation of Industry and Commerce Medical and Pharmaceutical Commercial Association was established in 2006 and composes national pharmaceutical companies, traditional Chinese medicine institutions, medical equipment manufacturers, hospitals, healthcare services, and other related enterprises, as well as academic and scientific research institutions. CMP serves as a key partner to the government in managing and supporting the pharmaceutical and healthcare industry. With over 5,000 member companies and 50 industry groups, CMP is vital in advancing the sector. This prestigious appointment reflects the medical industry' s high regard for Jafron' s remarkable achievements and Mr. Dong Fan’s outstanding leadership and significant contributions. Looking ahead, we remain committed to fostering collaboration with industry experts to promote the sustainable development of the medical sector and contribute to the overarching goal of a healthier society!

The iconic city of Riccione, Italy, was the venue for the 65th National Congress of the Italian Society of Nephrology, held from October 16th to 19th. B. Braun Avitum Italy SpA successfully partnered with Jafron Biomedical to set up a booth and host a symposium, which received an enthusiastic response from participants. Our active and communicative exhibition activities attracted numerous clinical professionals in related fields to interact and contribute their professional insights. Dr. Matteo Floris and Dr. Paolo Lentini gave impactful presentations, sharing their valuable clinical experiences and cutting-edge research. In addition. This year marks the 100th anniversary of of hemodialysis, and Prof. Ronco highlighted HA130 in his anniversary lectures, underscoring the high recognition of our products in hemodialysis treatment. We are grateful for the strong interest in our innovative technologies. Let's push the boundaries of nephrology together! #HA130 #Nephrology #Hemodialysis

On October 10 and 11 Jafron successfully co-organized the first joint academic event in Colombia with one of the most prestigious nephrology care providers in the region, along with FUCS University. Together with our local distributor, Colombian Medicare, we prepared a workshop on the Double Plasma Molecular Adsorption System (DPMAS) and a hemoadsorption workshop for intoxicated patients. The event featured practical demonstrations of the JF-800A, combining theoretical knowledge with hands-on operations. A total of 40 participants attended, including experienced nephrologists, local intensivists, nephrology residents, and medical scholars from the university. It is worth highlighting that we had the honor of hosting the renowned Colombian nephrologist, Dr. David Ballesteros, who shared his insights on the application of the HA230 in the field of poisoning, drawing from his deep academic knowledge and extensive clinical experience. We extend our sincere thanks to our Latam Clinical Manager, Emilben Zambrano, for successfully organizing this event, and to all the participants for their support and engagement in the valuable exchange of ideas and current trends in nephrology. We eagerly anticipate the positive impact that hemoadsorption will have in Colombia!

"The ESICM2024 expert's lecture received an enthusiastic response, and the Jafron IBU team worked together seamlessly, delivering an outstanding performance."

Today's expert lectures from Spain and the product pre-launch event drew a large crowd of doctors, who remained engaged and offered positive feedback. Additionally, 11 Vietnamese experts visited the booth for discussions, exchanges, and photos. #ESICM2024 #Jafron #Hemoadsorption

"Join us at ESICM booth 1.06 for exciting activities and an exclusive reveal of our New Era of Adsorption. Don't miss out!" #ESICM2024 #Jafron #Hemoadsorption

"Our New Era of Adsorption innovation is about to be unveiled—stay tuned for the big reveal!" #ESICM2024 #Jafron #Hemoadsorption